Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and alzheimer disease

Acta Radiologica

Volumn 50, Issue 3, 2009, Pages 312-319

  Wang, Zhiqun ^a   Zhao, Cheng ^a   Yu, Lei ^a   Zhou, Weidong ^a   Li, Kuncheng ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer disease; Magnetic resonance spectroscopy; Mild cognitive impairment

Indexed keywords

ALZHEIMER DISEASE; COGNITIVE DECLINE; COGNITIVE IMPAIRMENT; CONTROL GROUPS; EARLY DIAGNOSIS; METABOLIC CHANGES; METABOLITE CHANGES; MILD COGNITIVE IMPAIRMENT; MYO-INOSITOL; N-ACETYLASPARTATE; NEUROPSYCHOLOGICAL TESTS; SPECTROSCOPIC DATA;

CHROMIUM; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM; METABOLITES; PARTICLE DETECTORS; SUGARS;

DIAGNOSIS;

ASPARTIC ACID; CREATINE; DRUG DERIVATIVE; INOSITOL; N ACETYLASPARTIC ACID; N-ACETYLASPARTATE;

AGED; ALZHEIMER DISEASE; ARTICLE; CINGULATE GYRUS; COGNITIVE DEFECT; COMPARATIVE STUDY; ENERGY METABOLISM; FEMALE; HEMISPHERIC DOMINANCE; HIPPOCAMPUS; HUMAN; IMAGE PROCESSING; MALE; MENTAL HEALTH; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASPARTIC ACID; COGNITION DISORDERS; CREATINE; DOMINANCE, CEREBRAL; ENERGY METABOLISM; FEMALE; GYRUS CINGULI; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED;

EID: 64149098278     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850802709219     Document Type: Article

References (32)

1. Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hanninen T, Laakso MP, et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 2004;25:303-10.
2. Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397-403.
3. Vogt BA, Van Hoesen GW, Vogt LJ. Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer disease. Acta Neuropathol 1990;80:581-9.
4. 1H MR spectroscopic findings in Alzheimer's disease. Neuroimag Clin N Am 2005;15:847-52.
5. Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, et al. Selective reduction of N-acetylas-partate in medial temporal and parietal lobes in AD. Neurology 2002;58:928-35.
6. Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, et al. Different patterns of N-acetylas-partate loss in subcortical ischemic vascular dementia and AD. Neurology 2003;61:358-64.
7. 1H MRS study. Neurology 2000;55:210-7.
8. 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease. Brain Res 2004;1003:26-35.
9. Kantarci K, Xu Y, Shiung MM, O'Brien PC, Cha RH, Smith GE, et al. Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord 2002;14:198-207.
10. Jessen F, Block W, Traber F, Keller E, Flacke S, Lamerichs R, et al. Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology 2001;57:930-2.
11. Kantarci K, Reynolds G, Petersen RC, Boeve BF, Knopman DS, Edland SD, et al. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T. Am J Neuroradiol 2003;24:843-9.
12. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C.; American Psychiatric Association; 1994.
13. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-70.
14. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56: 303-8.
15. Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myoinositol with proton MR spectroscopy. Radiology 1993;187:433-7.
16. 1H MRS study. Neurology 2001;57:626-32.
17. Block W, Jessen F, Träber F, Flacke S, Manka C, Lamerichs R, et al. Regional N-acetylaspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with Alzheimer disease. Arch Neurol 2002;59:828-34.
18. Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. Arch General Psychiatry 1999;56:185-92.
19. Parnetti L, Tarducci R, Presciutti O, Lowenthal DT, Pippi M, Palumbo B, et al. Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging. Mech Ageing Dev 1997;97:9-14.
20. Lazeyras F, Charles HC, Tupler LA, Erickson R, Boyko OB, Krishnan KR. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy. Psychiatry Res 1998;82:95-106.
21. 1H MR spectroscopic imaging. Radiology 1996;198:537-45.
22. 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. Magn Reson Imaging 1999;17:291-9.
23. Zhu X, Schuff N, Kornak J, Soher B, Yaffe K, Kramer JH, et al. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging. Alzheimer Dis Assoc Disord 2006;20:/77-85.
24. Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, et al. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:1313-22.
25. Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology 2001;56:592-8.
26. Moats RA, Ernst T, Shonk TK, Ross BD. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 1994;32: 110-5.
27. 1H magnetic resonance spectroscopic imaging. Magn Reson Med 2001;45:899-907.
28. 1H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging. Neuroreport 2001;12:2315-7.
29. Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2005;384:23-8.
30. Chantal S, Labelle M, Bouchard RW, Braun CM, Boulanger Y. Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease. Arch Neurol 2002;59:955-62.
31. 1H magnetic resonance spectroscopy. Eur J Neurol 2004;11: 187-93.
32. Engelhardt E, Moreira DM, Laks J, Cavalcanti JL. Alzheimer's disease and proton magnetic resonance spectroscopy of limbic regions: a suggestion of a clinical-spectroscopic staging. Arq-Neuropsiquiatr 2005; 63:195-200.